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We evaluated the clonality of seborrheic keratoses
using a polymorphism due to the random inactiva-
tion of one of two X chromosomes in females.
Thirty-eight seborrheic keratoses obtained from the
skin of females with polymorphism of the human
androgen receptor (HUMARA) locus were examined
by a ¯uorescent polymerase chain reaction proced-
ure, which allowed accurate measurement of the
peak intensities of each HUMARA allele. The epithe-
lial portion of seborrheic keratosis and normal con-
trol epidermis adjacent to the seborrheic keratosis
were removed by laser capture microdissection. As
biopsied specimens of seborrheic keratoses contained
small amounts of normal epidermis, the effect of
digestion by a restriction enzyme (HhaI) recognizing
the nonmethylated active sites was compared
between seborrheic keratoses and normal control
epidermis in only ®ve seborrheic keratosis cases.
Disappearance or signi®cant reduction in intensity of
one of two HUMARA alleles was observed after
HhaI digestion in seborrheic keratoses, but not in the
normal control epidermis. Although the skewing of
the polymorphism was not corrected by the normal
control epidermis in the remaining 33 seborrheic
keratosis cases, one of two HUMARA peaks practic-
ally disappeared after HhaI digestion in 20 of 33
seborrheic keratosis cases. In total, 25 of 38 sebor-
rheic keratoses were considered to be monoclonal.
The histologic type of seborrheic keratoses did
not affect clonality. Key words: clonality/human andro-
gen receptor gene/seborrheic keratosis/X chromosome inacti-
vation mosaicism. J Invest Dermatol 116:506±510, 2001
S
eborrheic keratosis (SK) is one of the most common
benign lesions of the human epidermis (Stewart et al,
1978; Mackie, 1992; Ho and McLean, 1993; Kirkham,
1997). SK do not usually appear before middle age, and
occur mainly on the trunk and face, but also on the
extremities, with the exception of the palms and soles (Kirkham,
1997). They show a considerable variety of histologic appearances,
and six types are recognized: acanthotic, hyperkeratotic, reticulated,
clonal, irritated, and melanoacanthoma. Often, more than one type
is found in the same lesion, and all types show hyperkeratosis,
acanthosis, and papillomatosis (Kirkham, 1997).
The etiology of SK is unknown. Whether SK are hyperplastic or
neoplastic has not yet been determined. If SK is a hyperplasia of the
epidermis, it does not originate from a single epithelial cell and
therefore is polyclonal; however, if it is a neoplasia, SK is
monoclonal. As an examination of clonality appeared to promote
understanding of the etiology of SK, we investigated this point. As
epithelial tumors of the skin, verrucae vulgaris were ®rst demon-
strated to be monoclonal (Murray et al, 1971). Basal cell carcinomas
are also shown to be monoclonal (Walsh et al, 1996, 1998).
Although the former is benign and the latter malignant and,
although the former is caused by a human papillomavirus, both of
these epithelial lesions are now considered to be neoplasia.
To examine the clonality of human samples, random inactivation
of one of two female X chromosomes is most commonly used
(Vogelstein et al, 1985, 1987). Currently, the polymorphism of the
human androgen receptor (HUMARA) locus, which is located on
the X chromosome, is most frequently used as it has a highly
polymorphic tandem repeat (Allen et al, 1992). Approximately 90%
of females are heterozygous for the number of CAG trinucleotide
repeats (Allen et al, 1992). Moreover, methylation-sensitive
restriction sites of HpaII and HhaI are within the HUMARA
locus (Allen et al, 1992), and the base pairs ampli®ed by polymerase
chain reaction (PCR) are relatively small (Mashal et al, 1993). We
obtained pure SK lesions using a laser capture microdissection
(LCM) system (Emmert-Buck et al, 1996; Simone et al, 1998). A
clonality assay using the polymorphism of the HUMARA locus
indicated that more than half the SK were monoclonal in nature.
MATERIALS AND METHODS
SK samples SK lesions were biopsied from nongenital regions of 40
female patients, ranging in age from 29 to 90 y. Diagnosis was made
under a microscope by examining paraf®n sections stained with
hematoxylin and eosin. Of the 32 specimens in which the location was
speci®ed, 12 were from the trunk, seven from the face, six from the
neck, ®ve from the upper limbs, and two from the lower limbs. Forty-
four SK obtained from 40 patients were histologically classi®ed into the
following four types: acanthotic (27), hyperkeratotic (14), reticulated
(two), and irritated (one).
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DNA extraction DNA samples were extracted from the formalin-
®xed, paraf®n-embedded tissues according to a previous method (Mashal
et al, 1993). The SK lesion and normal control epidermis adjacent to the
SK lesion were microdissected from 6 mm sections stained with
hematoxylin and eosin using an LCM system (LM200, Arcturus
Engineering, Mountain View, CA). A representative SK sample is shown
in Fig 1. A total volume of 20 ml of PK buffer containing 1.0%
proteinase K, 10 mM Tris±HCl (pH 8.0), 1 mM ethylenediamine
tetraacetic acid, and 1% Tween 20 was mounted on a microdissected
specimen attached to a piece of LCM Transfer Film (Arcturus
Engineering). Then, a 0.5 ml micro test-tube (Eppendorf-Nethtler-Hinz-
GmbH, Hamburg, Germany) was placed over it. After 16 h incubation
at 37°C, proteinase K was inactivated by heating at 95°C for 10 min.
The lysis mixture was centrifuged for 5 min to remove undigested tissue
fragments.
Clonality assessment We used a quantitative ¯uorescent PCR
procedure that enables accurate measurement of the peak intensities of
each allele according to a previous report (Wu et al, 1999). The
HUMARA gene includes a polymorphic [(CAG)n] repeat located at 3¢
of the methylation-sensitive HhaI restriction-enzyme sites (Allen et al,
1992). The PCR assay used primers, the product of which spanned both
the HhaI sites and the [(CAG)n] polymorphism. Variations in length of
the [(CAG)n] repeats on the paternal and maternal X chromosomes yield
HUMARA alleles of different lengths. Methylation of the HhaI sites
distinguishes the active (nonmethylated) from the inactive (methylated)
X chromosome. It is only the undigested inactive methylated allele that
is subsequently ampli®ed by PCR (Allen et al, 1992).
Each SK DNA sample or nonlesional epidermis (7.5 ml) was digested
overnight at 37°C in a 2.5 ml reaction mixture containing 0.5 ml of
16 units of HhaI (TOYOBO, Osaka, Japan), 1 ml of concentrated
(3 10) TA buffer (330 mM Tris-acetate, 660 mM KOAc, 100 mM
MgOAc2, 5 mM dithiothreitol), and 1 ml of concentrated (3 10) bovine
serum albumin. For each case, a control sample containing only a
restriction-enzyme buffer was run simultaneously. The restriction enzyme
was then inactivated by heating at 95°C for 10 min.
For the PCR, 1 ml of each digested DNA sample was added to 24 ml
of a PCR reaction mixture containing 2.5 ml of concentrated (3 10)
PCR buffer, 1.5 ml of deoxyribonucleoside triphosphate (200 mM),
0.2 ml of primers 1A and 1B (10 pM each), 0.1 ml of Taq polymerase
(Boehringer Mannheim GmbH, Mannheim, Germany) and 19.7 ml of
deionized H2O. The DNA samples were ampli®ed using a sandwiched
primer approach (Fujita et al, 1996). The ®rst step was performed using
outer primers 1A (5¢-GCT GTG AAG GTT GCT GTT CCT CAT-3¢)
and 1B (5¢-CGT CCA AGA CCT ACC GAG GAG CTT-3¢). The sec-
ond step was performed with inner primers 2A (5¢-
TCC AGA ATC TGT TCC AGA GCG TGC-3¢) and 2B (5¢-
ATG GGC TTG GGG AGA ACC ATC CTC-3¢). Primer 2A was
labeled at the 5¢ end with 6-carboxy¯uorescein. Initial denaturation was
performed for 10 min at 95°C, followed by 30 cycles of 1 min at 95°C,
1 min at 60°C, and 1 min at 72°C. In the ®nal cycle, extension at 72°C
was prolonged for 10 min. The second-step PCR pro®le was the same
as the ®rst-step PCR. Following the second-step ampli®cation, 5 ml of
the PCR product was assessed using 2.0% agarose gel electrophoresis to
con®rm the ampli®cation of the HUMARA target.
After ampli®cation, 1 ml of the PCR products was mixed with 12 ml
of a Template Suppression Reagent (Applied Biosystems, Foster City,
CA) and 0.5 ml of internal size standards [GENESCAN-500 (TAMRA),
Applied Biosystems). The mixture was denatured at 95°C for 2 min, and
analyzed through a DNA Sequencing Polymer (Applied Biosystems) with
an ABI PRISM Genetic Analyzer (Applied Biosystems), according to a
previous method (George et al, 1997). Data were analyzed using
Genescan 310 Software (Applied Biosystems).
Data interpretation Ampli®cation of each HUMARA allele usually
generated a set of multiple peaks, including one major peak and a few
associated peaks of lesser intensity as described previously (Paradis et al,
1997). Clonality assessment was based on the major peak generated from
each allele. Patients were considered heterozygous when PCR
ampli®cation of undigested DNA showed two major peaks of almost
equal intensity. This suggested that maternal and paternal X
chromosomes have HUMARA alleles of different molecular weights.
PCR products showing a single major peak suggested that maternal and
paternal X chromosomes have HUMARA alleles of the same molecular
weight. Such patients were considered to be homozygous for the
HUMARA gene, and thus uninformative for the analysis.
For each sample, the peak intensities of two alleles (the allele with the
lower molecular weight and the allele with the higher molecular weight)
were measured. A corrected ratio (CR) was assessed by dividing the ratio
of the HhaI-digested sample (the allele with the lower molecular weight/
the allele with the higher molecular weight) by the ratio of the
undigested sample. The use of CR corrects for the preferential ampli®-
cation of one allele that can occur if the alleles differ markedly in
molecular weight (Paradis et al, 1997). The ratio was inverted, if
necessary, to obtain a value of over 1.0.
When enough DNA was obtained from the normal epidermis adjacent
to the SK lesion, the ®nal clonality ratio for each SK was determined by
dividing the CR of the lesional DNA by the CR of the nonlesional
DNA. This ®nal clonality ratio corrects for any potential skewed
lyonization. We assumed that SK with a ®nal clonality ratio of > 1.5
were monoclonal, according to a previous report (Paradis et al, 1997).
Statistical analysis Statistical analysis was performed using Microsoft
Excel (Microsoft, WA). The data are presented as mean and SEM.
Differences between groups were evaluated by Student's t test.
RESULTS
SK specimens were obtained from 40 women. Sections from the
SK lesions were stained with hematoxylin and eosin, and histologic
types were determined. Then, the epithelial portions of the
individual SK lesions were carefully removed by LCM (Fig 1).
DNA was extracted from each sample, and the portion of the
HUMARA locus containing the trinucleotide repeats was ampli-
®ed by PCR. Samples derived from six of 40 patients could not be
used because the polymorphism of the HUMARA locus was not
detectable. The remaining 34 patients were considered to be
informative. As three of 34 informative patients (12, 17, and 27)
had two or three SK, 38 SK lesions were analyzed in total
(Table I).
Histologic types, allelic sizes, and CR values of informative SK
cases are shown in Table I. As biopsied SK specimens contained
relatively small amounts of normal epidermis adjacent to the SK,
CR values of the normal control epidermis were obtained in only
®ve SK cases, and the ®nal clonality ratio was calculated by dividing
the CR of each SK by the CR of the normal control epidermis
(Table I). The ®nal clonality ratio of these ®ve SK was > 1.5.
CR values were plotted against numbers of bases that were
different between two HUMARA alleles of individual SK (Fig 2).
The CR values appeared to be dependent on the number of bases,
being different between alleles of lower molecular weight and those
of higher molecular weight. CR values were > 10 in none of the
10 SK in which 3 bp were different between the two alleles, in ®ve
of 10 SK in which 6 bp were different between the two alleles, and
in 16 of 18 SK in which > 9 bp were different between the two
alleles (Fig 2). In total, CR values were > 10 of 21 of the 38 SK
examined.
Figure 1. A SK lesion removed from patient no. 24 using the
LCM system. Scale bar: 500 mm.
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When the number of bases that differed between the two alleles
was 3 or 6, the variation in CR values was signi®cant among
individual SK (Fig 2). The following tendency was observed. CR
values were higher when the HUMARA alleles with higher
molecular weights were activated and digested than when the allele
with a lower molecular weight were activated and digested (Fig 3).
For example, compare Fig 4(4A1) (CR = 8.1) and Fig 4(4A2)
(CR = 1.7), and Fig 4(4B1) (CR > 10) and Fig 4(4B2)
(CR = 3.8). The number of bases that differed between the two
HUMARA alleles was three in the cases shown in Fig 4(4A1,
4A2). Also, the number of bases that differed between the two
alleles was six in the cases shown in Fig 4(4B1, 4B2).
DISCUSSION
In this study, we examined the clonality of SK. Biopsy specimens of
SK contained only small amounts of normal epidermis. Therefore,
we obtained enough normal control epidermis in only ®ve SK
cases; however, in these ®ve SK cases, the CR values of the normal
epidermis were < 1.1. In other words, no signi®cantly skewed
lyonization of the normal epidermis was detected in these ®ve cases.
The ®nal clonality ratio was calculated by dividing the CR value of
each SK by that of the control normal epidermis. As a ®nal ratio of
> 1.5 has been used as a criterion for monoclonality (Paradis et al,
1997), we considered that at least these ®ve SK were monoclonal.
The skewing was different among various tissues from each
patient. We dissected the normal epidermis using an LCM system;
such skewing of the normal human epidermis has not been
reported to our knowledge. To establish the normal range of CR
values for the normal human epidermis, the examination of more
skin samples using the present method appears to be necessary.
The slippage phenomenon observed in Taq ampli®cation of
trinucleotide repeats may result in minor peaks trailing the major
peak at 3 bp intervals (Mutter and Boynton, 1995). This interfer-
ence is insigni®cant when two alleles differ by 9 bp or more in size.
Figure 2. Interrelationship between CR values and numbers of
bases that were different between two HUMARA alleles of
individual SK. d, the SK in which the HUMARA allele with higher
molecular weight was digested. s, the SK in which the HUMARA
allele with lower molecular weight was digested.
Figure 3. Effect of the size of the HUMARA allele to be digested
on CR values in SK in which the two HUMARA alleles differed
by 3 or 6 bp. The same results as shown Fig 2. The SK cases in which
the allele with higher molecular weight was digested were compared
with those in which the allele with a lower molecular weight was
digested. Between CR values of these two groups, a signi®cant
difference was observed (p < 0.01 by t test).
Table I. Histologic types, size of alleles, corrected ratios
and ®nal ratios of SK cases
Patient
no.
Histologic
typea
Size of alleles
(difference in
bases)
CR Final ratio
(SK/normal
epidermis)SK Normal
epidermis
1 AC 222/225 (3) 1.5
2 AC 219/222 (3) 1.6
3 AC 231/234 (3) 1.7
4 AC 225/228 (3) 2.5
5 AC 228/231 (3) 2.9
6 AC 216/219 (3) 3.1
7 AC 237/240 (3) 3.8
8 AC 228/231 (3) 4.3
9 AC 225/228 (3) 8.1
10 ACb 216/222 (6) 2.7 1.1 2.5
11 AC 225/231 (6) 3.8
12 AC 225/231 (6) 8.7
ACc 225/231 (6) > 10
13 ACc 228/234 (6) > 10
14 ACc 222/228 (6) > 10
15 ACc 222/231 (9) 10.0
16 ACb 231/243 (12) 2.5 1.0 2.5
17 ACc 234/246 (12) > 10
ACc 234/246 (12) > 10
18 ACb 222/237 (15) 6.0 1.1 5.5
19 ACc 207/222 (15) > 10
20 ACc 222/237 (15) > 10
21 ACc 228/246 (18) > 10
22 ACc 204/222 (18) > 10
23 HY 231/237 (6) 2.0
24 HYb 225/231 (6) 4.2 1.1 3.8
25 HYc 234/240 (6) > 10
26 HYb,c 228/237 (9) > 10 1.0 > 10
27 HYc 228/237 (9) > 10
HYc 228/237 (9) > 10
REc 228/237 (9) > 10
28 HYc 234/243 (9) > 10
29 HYc 237/246 (9) > 10
30 HYc 216/228 (12) > 10
31 HYc 225/237 (12) > 10
32 HYc 222/237 (15) > 10
33 RE 228/231 (3) 1.6
34 IRc 228/234 (6) > 10
aAC, acanthotic; HY, hyperkeratotic; RE, reticulated; IR, irritated.
bConsidered monoclonal because the ®nal ratio is > 1.5.
cConsidered monoclonal because CR is > 10.0.
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The two alleles differed by 9 bp or more in the 18 SK, which were
examined in this study. In 16 of these 18 SK, one of two
HUMARA peaks practically disappeared after digestion by HhaI
(i.e., CR values > 10.0). Therefore, at least these 16 SK were
considered to be clonal.
When the two alleles differed by 6 bp, one of two HUMARA
peaks also disappeared after HhaI digestion (CR > 10.0) in ®ve of
10 SK cases (Fig 2). We concluded that these ®ve cases were also
monoclonal. Overall, ®ve SK were considered to be monoclonal
because the ®nal ratios were > 1.5, and 21 SK were judged to be
monoclonal because their CR values were > 10.0. As both criteria
were applicable to only one SK (patient 26), 25 of 38 SK examined
were judged to be monoclonal (Table I). This does not imply that
the remaining 13 SK were polyclonal. Although they were not
determined to be monoclonal using the present method, some of
them may have been monoclonal if genes on the X chromosome
other than the HUMARA gene had been used as a marker of
clonality.
The clonality of various skin tumors has been reported. As for
epidermal tumors, verrucae vulgaris (Murray et al, 1971) and basal
cell carcinomas (Walsh et al, 1996, 1998) have been shown to be
monoclonal. In this study, we demonstrated that more than half of
the SK were also monoclonal. Regarding mesenchymal tumors,
dermato®bromas were reported to be monoclonal (Chen et al,
2000). Although the monoclonality of benign neuro®bromas is
controversial (Rey et al, 1987; Skuse et al, 1991; Daschner et al,
1997), neuro®brosarcomas that developed from neuro®bromas
were monoclonal (Friedman et al, 1982). With Kaposi's sarcoma,
controversial results have been reported (Rabkin et al, 1995, 1997;
Delabess et al, 1997; Gill et al, 1998). Although melanomas have
been shown to be monoclonal, results regarding nevocellular
neavus are controversial (Harada et al, 1997; Robinson et al, 1998).
Many nontumor cells may be present within tumors.
Microdissection of tissue fragments that contain tumor cells
alone, and examination of clonality by a sensitive and quantitative
method may be necessary to reach de®nite conclusions.
As mentioned previously, one artifact that may prevent accurate
quantitative analysis using the present method is the slippage
phenomenon observed in Taq ampli®cation of trinucleotide
repeats. When alleles differ by 3 or 6 bp in size, the presence of
a secondary or tertiary peak may preclude the accurate analysis (Wu
et al, 1999). We pooled the CR values of SK in which the two
alleles differed by 3 and 6 bp in size. The CR values were
signi®cantly higher when alleles with higher molecular weights
were digested than when alleles with lower molecular weights were
digested (Fig 3). If alleles with higher molecular weights were
digested, the intensity of the undigested alleles with lower
molecular weights was unaffected (Fig 4 4A1, 4B1). In contrast,
even if an allele with a lower molecular weight was digested, a
secondary or tertiary peak of an undigested allele with higher
molecular weight remained at the position where the digested peak
had been situated.
Thirty-eight informative SK were histologically classi®ed into
acanthotic, hyperkeratotic, reticulated, or irritated types. SK that
were demonstrated to be monoclonal were found in all histologic
types. There was no correlation between histologic type and
clonality (Table I).
In this study, we showed the monoclonal origin of more than
half the SK in the skin of human females, suggesting that SK are a
benign neoplasia. Although the biology of SK has not been studied
in depth, it is possible that further investigation may be useful in
understanding the development and progression of benign tumors
in human skin.
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